Lyell Immunopharma Growth Metrics (2020-2025) | LYEL

Growth Metrics Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 0.08M0.16M-0.13M-1.10M0.23M-239.49M0.30M-8.41M-23.10M219.80M-39.88M-193.53M-12.12M7.09M-135.03M128.50M-18.25M-13.03M
EBITDA Margin Growth (3y) -22.78M-19.52M-39.71M-203.03M-34.99M-12.59M-174.61M-73.43M-53.47M213.86M
EBITDA Margin Growth (5y) -53.16M-25.46M
EBITDA Margin (QoQ) -0.02M0.17M-0.06M-0.01M0.06M-0.12M-1.02M1.31M-239.65M239.66M-9.73M-13.38M3.25M-20.02M-163.38M168.02M22.46M-162.14M100.16M21.27M27.68M
EBIT Margin Growth (1y) 0.09M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M
EBIT Margin Growth (3y) -24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M
EBIT Margin Growth (5y) -58.60M-24.49M
EBIT Margin (QoQ) -0.02M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M
EBT Margin Growth (1y) 0.09M0.16M955.00-1.01M0.23M-213.78M0.16M-7.70M-22.45M192.98M-40.32M-153.59M-12.28M7.87M-138.06M86.08M-20.09M-9.56M
EBT Margin Growth (3y) -22.14M-20.64M-40.16M-162.29M-34.50M-12.92M-178.22M-75.20M-54.82M191.30M
EBT Margin Growth (5y) -54.51M-22.32M
EBT Margin (QoQ) -0.01M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.22M-213.94M213.95M-8.93M-13.53M1.49M-19.35M-122.19M127.78M21.64M-165.29M101.95M21.61M32.17M
Enterprise Value Growth (1y) -533.70%-234.60%-358.87%-0.36%-151.22%20.49%-4.72%-4.12%0.19%9.12%11.22%14.67%14.11%17.56%23.44%32.17%42.77%43.64%27.45%
Enterprise Value Growth (3y) -87.78%-34.21%-62.19%3.75%-29.14%15.86%10.71%15.53%21.13%24.98%20.99%
Enterprise Value Growth (5y) -30.83%-2.35%-18.83%
Enterprise Value (QoQ) 45.26%-354.20%60.11%-237.41%24.94%0.67%0.14%-6.78%1.13%1.23%4.28%2.78%3.41%5.08%3.65%6.68%10.30%15.89%18.72%8.10%-15.48%
FCF Margin Growth (1y) 0.19M0.07M-0.83M0.21M-132.85M0.14M-6.30M-14.84M117.83M-31.27M-133.44M-14.56M4.83M-11.71M62.24M-13.87M-8.77M
FCF Margin Growth (3y) -14.83M-31.05M-140.57M-29.19M-10.19M-42.83M-77.51M-43.27M113.89M
FCF Margin Growth (5y) -18.77M
FCF Margin (QoQ) 0.10M0.01M-0.01M0.09M-0.02M-0.89M1.03M-132.97M132.97M-7.34M-7.50M-0.30M-16.12M-109.51M111.38M19.09M-32.66M-35.56M35.27M24.19M
Net Margin Growth (1y) 0.09M0.16M955.00-1.01M0.23M-213.78M0.16M-7.70M-22.45M192.98M-40.32M-153.59M-12.28M7.87M-138.06M86.08M-20.09M-9.56M
Net Margin Growth (3y) -22.14M-20.64M-40.16M-162.29M-34.50M-12.92M-178.22M-75.20M-54.82M191.30M
Net Margin Growth (5y) -54.51M-22.32M
Net Margin (QoQ) -0.01M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.22M-213.94M213.95M-8.93M-13.53M1.49M-19.35M-122.19M127.78M21.64M-165.29M101.95M21.61M32.17M
Operating Margin Growth (1y) 0.09M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M
Operating Margin Growth (3y) -24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M
Operating Margin Growth (5y) -58.60M-24.49M
Operating Margin (QoQ) -0.02M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M
Return on Assets Growth (1y) -5.000.00M2.00-3.00-1.00-10.00-11.00-7.00-8.00-31.00-44.00-53.00-53.00
Return on Assets Growth (3y) -13.00-42.00-53.00-64.00-61.00
Return on Assets (QoQ) -1.00-2.001.00-2.003.000.00M-4.000.00M-7.00-1.000.00M0.00M-30.00-13.00-9.000.00M
Return on Capital Employed Growth (1y) -5.00-1.001.00-5.00-3.00-13.00-14.00-10.00-10.00-38.00-51.00-61.00-58.00
Return on Capital Employed Growth (3y) -18.00-52.00-65.00-76.00-71.00
Return on Capital Employed (QoQ) -1.00-2.001.00-3.003.000.00M-5.000.00M-8.00-1.000.00M-1.00-36.00-14.00-10.002.00
Return on Equity Growth (1y) -85.00-99.0033.00-5.001.004.00-3.000.00M-11.00-13.00-8.00-9.00-40.00-60.00-72.00-70.00
Return on Equity Growth (3y) -96.00-108.0022.00-14.00-51.00-69.00-83.00-79.00
Return on Equity (QoQ) 11.00-129.0035.00-2.00-3.002.00-3.004.001.00-5.000.00M-8.00-1.000.00M-1.00-38.00-21.00-12.002.00
Return on Sales Growth (1y) 851.000.00M10.00-0.01M0.00M-2.14M0.00M-0.08M-0.22M1.93M-0.40M-1.54M-0.12M0.08M-1.38M0.86M-0.20M-0.10M
Return on Sales Growth (3y) -0.22M-0.21M-0.40M-1.62M-0.35M-0.13M-1.78M-0.75M-0.55M1.91M
Return on Sales Growth (5y) -0.55M-0.22M
Return on Sales (QoQ) -112.000.00M-567.00-128.00603.00102.00-0.01M0.01M-2.14M2.14M-0.09M-0.14M0.01M-0.19M-1.22M1.28M0.22M-1.65M1.02M0.22M0.32M